Revenio Group Oyj Stock: price and insider trades · Finland

Revenio Group Oyj is a Health Care company. Its directors and officers file their transactions with Nasdaq Helsinki. Between 18 October 2025 and 18 October 2026, 21 insiders published 29 filings.

On the market, 4 insiders bought (6 purchases totalling €58k) while 2 insiders sold (2 sales totalling €3,801). Taken together, the purchases exceed the sales by €54k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 2 board members and 2 senior executives. At €36k, the purchase published on 30 September 2026 by Ari Isomäki is the largest of the period (0.0097% of market cap).

With 29 filings in twelve months, the company is more active than the median of 15 filings across the 126 companies we follow on the same exchange. Our records for Revenio Group Oyj go back to 2022, with 35 purchases and 9 sales on the open market in total.

The data flag 3 purchases as part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. The last purchase on record was published on 7 October 2026, which is 10 days ago. The median gap between a trade and its publication by Nasdaq Helsinki is 1 day. For comparison, MAR article 19 gives managers three business days to notify a trade.

For comparison within the same sector, see the insider buying recorded at Anixa Biosciences Inc and Vivos Inc. This summary is built from Nasdaq Helsinki disclosures alone and does not predict where the share price will go.